Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
<p><strong>Aims:</strong><br /> To compare the benefits and harms of naltrexone–bupropion using evidence from clinical study reports.</p><br /> <p><strong>Methods:</strong><br /> We searched Food and Drug Administration and European Medici...
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
Wiley
2020
|